𝔖 Bobbio Scriptorium
✦   LIBER   ✦

THE PRESENCE OF CYTOKINES IN LANGERHANS' CELL HISTIOCYTOSIS

✍ Scribed by DE GRAAF, JAN H.; TAMMINGA, RIENK Y. J.; DAM-MEIRING, ANKE; KAMPS, WILLEM A.; TIMENS, WIM

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
788 KB
Volume
180
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

✦ Synopsis

Langerhans' cell histiocytosis (LCH) is characterized by an accumulation and/or proliferation of cells with a Langerhans' cell (LC) phenotype. The aetiology and pathogenesis of LCH are unknown; it is suggested that LCH is caused by an immunological dysregulation. Production of cytokines is a central feature of immunological regulation. LCH lesions and normal LCs were studied for the presence of cytokines known to influence the functioning of LCs: IL-1 alpha, IL-1 beta, IL-4, GM-CSF, IFN-gamma, TGF-alpha, TGF-beta, bFGF, and TNF-alpha. Cytokines were abundantly present within LCH lesions; LCH cells stained for IL-1 alpha, IL-1 beta, IL-4, GM-CSF, TGF-alpha, TGF-beta, TNF-alpha, and IFN-gamma. Macrophages, lymphocytes, eosinophil granulocytes, and, surprisingly, multinucleated giant cells were also sources of cytokines. These results suggest that cytokines play a prominent role in the pathogenesis of LCH and may explain phenomena that often occur in LCH, such as osteolysis and fibrosis and the recruitment of typical inflammatory infiltrates. The results also suggest that a 'down-regulatory' signal is lacking in LCH, resulting in an accumulation and/or proliferation of abnormal LCs.

πŸ“œ SIMILAR VOLUMES

Langerhans cell histiocytosis in the adu
Langerhans cell histiocytosis in the adult
✍ Malpas, J. S.; Norton, A. J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 532 KB

A study of 47 well-documented patients with Langerhans cell histiocytosis (LCH) showed a slight female preponderance, with onset as late as the ninth decade. The skin was the commonest site of presentation, but pulmonary and bone involvement was frequent. Patients with single-site disease did best.

Langerhans'-cell histiocytosis in adults
Langerhans'-cell histiocytosis in adults
✍ Baumgartner, Iris; von Hochstetter, Arthur; Baumert, Brigitta; Luetolf, Urs; Fol πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 1 views

Guided by a long-term retrospective observa-bone lesions (n Ο­ 27), which remained asymption, the clinical course and treatment of Langer-tomatic or showed a remission to treatment, hans'-cell histiocytosis (LCH) in adult patients multifocal LCH had a more aggressive course. are represented. The seri

Use of indomethacin in Langerhans cell h
Use of indomethacin in Langerhans cell histiocytosis
✍ Munn, Stephanie E.; Olliver, Lucy; Broadbent, Valerie; Pritchard, Jon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 2 views

Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie

Radiation therapy in the management of l
Radiation therapy in the management of langerhans cell histiocytosis
✍ Selch, Michael T. ;Parker, Robert G. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 572 KB

## Abstract Twenty‐two patients with Langerhans cell histiocytosis (LCH) were managed in the UCLA Department of Radiation Oncology from 1974 to 1987. Their median age was 17 years (range 1–42 years) and median followup 4.5 years (range 1–13 years). Fourteen patients had disease localized to a bone

Ear involvement in childhood Langerhans'
Ear involvement in childhood Langerhans' cell histiocytosis
✍ Giammarco Surico; Paola Muggeo; Vito Muggeo; Valeria Conti; Chiara Novielli; Ann πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

Background. Ear involvement (EI) in Langerhans' cell histiocytosis (LCH) occurs quite often. We reviewed the Italian pediatric population of 251 children with LCH diagnosed between 1982 and 1995, focusing on EI, to highlight the prevalence, the clinical presentation, the outcome during follow-up, an